Preparation and properties of radioactive rhenium glass microspheres intended for in vivo radioembolization therapy.
Rhenium glass microspheres composed of metallic rhenium particles dispersed within a magnesium alumino borate glass matrix were produced by sintering ReO2 powder and glass frit at 1050 degrees C. The in vitro chemical durability of radioactive and nonradioactive microspheres was determined from chemical corrosion tests on microspheres immersed in phosphate-buffered saline (PBS) solution at 37 degrees C. The dosimetric properties of these microspheres also were calculated. The rhenium glass microspheres are chemically durable in body fluids and release < 1.2% of radioactive rhenium after being immersed in PBS solution for 32 days at 37 degrees C. Therapeutic radioactive rhenium activities can be obtained in < 10 h by neutron activation of these microspheres in a thermal neutron flux of 8 x 10(13) cm(-2)s(-1). A 50 mg injection of radioactive rhenium glass microspheres containing 3.7 GBq of 186Re and 8.5 GBq of 188Re could deliver a 100 Gy dose to a cancerous liver while limiting the total body dose from rhenium dissolution in vivo to approximately 1 mGy.
Conzone
S D
SD
Graduate Center for Materials Research Center and Ceramic Engineering Department, University of Missouri-Rolla, 65401, USA.
Häfeli
U O
UO
Day
D E
DE
Ehrhardt
G J
GJ
D001672:Biocompatible Materials; D001826:Body Fluids; D001918:Brachytherapy / Q000379:methods*; D004621:Embolization, Therapeutic / Q000379:methods*; D005898:Glass; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy; D008863:Microspheres; D011868:Radioisotopes; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D012211:Rhenium; D015021:Yttrium Radioisotopes
D001672:Biocompatible Materials; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes; D012211:Rhenium